Finance

Lists
DVLA:IDX
Darya-Varia Laboratoria Tbk PT
IDR 1,575.00
+0.32%
(+5.00) 1D
Nov 13, 4:00:05 PM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for DVLA...
Open
IDR 1,575
High
IDR 1,575
Low
IDR 1,570
Mkt. cap
1.76T
Avg. vol.
25.19K
Volume
7.40K
Dividend
6.67%
Quarterly dividend
IDR 26
Ex-dividend date
Jun 30, 2026
P/E ratio
12.40
52-wk high
IDR 1,695
52-wk low
IDR 1,420
EPS
IDR 127
Shares outstanding
1.12B
No. of employees
1K
Open
IDR 1,575
High
IDR 1,575
Low
IDR 1,570
Mkt. cap
1.76T
Avg. vol.
25.19K
Volume
7.40K
Dividend
6.67%
Quarterly dividend
IDR 26
Ex-dividend date
Jun 30, 2026
P/E ratio
12.40
52-wk high
IDR 1,695
52-wk low
IDR 1,420
EPS
IDR 127
Shares outstanding
1.12B
No. of employees
1K
News stories
From web sources and news partners
About Darya-Varia Laboratoria Tbk PT
CEO-
Employees1.34K
Founded1976
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
603.56B
594.80B
613.80B
639.90B
Cost of goods sold
282.05B
293.42B
307.37B
324.83B
Cost of revenue
282.05B
293.42B
307.37B
324.83B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
325.49B
232.36B
260.41B
257.29B
Operating expense
321.90B
229.76B
256.37B
255.32B
Total operating expenses
603.94B
523.18B
563.74B
580.15B
Operating income
-389.20M
71.62B
50.06B
59.74B
Other non operating income
-
-
-
-
EBT including unusual items
1.20B
72.98B
52.74B
64.01B
EBT excluding unusual items
742.83M
72.98B
51.36B
61.47B
Income tax expense
1.59B
17.67B
14.33B
15.06B
Effective tax rate
131.98%
24.21%
27.17%
23.52%
Other operating expenses
-3.59B
-2.60B
-4.04B
-1.97B
Net income
-384.24M
55.31B
38.41B
48.95B
Net profit margin
-0.06%
9.30%
6.26%
7.65%
Earnings per share
-
-
-
-
Interest and investment income
1.05B
662.79M
1.22B
1.05B
Interest expense
-5.36M
-1.93M
-1.49M
-1.05M
Net interest expenses
1.04B
660.86M
1.21B
1.05B
Depreciation and amortization charges
-
-
-
-
EBITDA
18.80B
92.79B
67.72B
79.60B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps